E-cigarettes and pregnancy. Is a closer look appropriate?

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 55, Issue 3, 2015, Pages 218-221

  Bryce, Robert ^a   Robson, Stephen J ^b  

^a FLINDERS UNIVERSITY   (Australia)

^b The Australian National University   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE;

CLINICAL TRIAL (TOPIC); ELECTRONIC CIGARETTE; FEMALE; HUMAN; MATERNAL SMOKING; NICOTINE REPLACEMENT THERAPY; NOTE; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; SMOKING CESSATION; SMOKING CESSATION PROGRAM; TOBACCO DEPENDENCE; ADVERSE EFFECTS; PROCEDURES;

ELECTRONIC CIGARETTES; FEMALE; HUMANS; NICOTINE; PREGNANCY; SMOKING CESSATION;

EID: 84937023121     PISSN: 00048666     EISSN: 1479828X     Source Type: Journal    
DOI: 10.1111/ajo.12318     Document Type: Note

References (41)

1. Cnattingius S. The epidemiology of smoking during pregnancy: smoking prevalence, maternal characteristics, and pregnancy outcomes. Nicotine Tob Res 2004; 6(suppl 2): S125-S140.
2. Mund M, Louwen F, Klingelhoefer D, Gerber A. Smoking and pregnancy - a review on the first major environmental risk factor of the unborn. Int J Environ Res Public Health 2013; 10: 6485-6499.
3. Johnston V, Thomas DP, McDonnell J, Andrews RM. Maternal smoking and smoking in the household during pregnancy and postpartum: findings from an Indigenous cohort in the Northern Territory. Med J Aust 2011; 194: 556-559.
4. Lumley J, Chamberlain C, Dowswell T et al. Interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev 2009; 3: CD001055.
5. McBride CM, Emmons KM, Lipkus IM. Understanding the potential of teachable moments: the case of smoking cessation. Health Educ Res 2003; 18: 156-170.
6. Fang WL, Goldstein AO, Butzen AY et al. Smoking cessation in pregnancy: a review of postpartum relapse prevention strategies. J Am Board Fam Pract 2004; 17: 264-275.
7. Mullen PD. How can more smoking suspension during pregnancy become lifelong abstinence? Lessons learned about predictors, interventions, and gaps in our accumulated knowledge. Nicotine Tob Res 2004; 6(Suppl 2): S217-S238.
8. Einarson A, Riordan S. Smoking in pregnancy and lactation: a review of risks and cessation strategies. Eur J Clin Pharmacol 2009; 65: 325-330.
9. Schneider S, Huy C, Schutz J, Diehl K. Smoking cessation during pregnancy: a systematic literature review. Drug Alcohol Rev 2010; 29: 81-90.
10. Berlin I, Grange G, Jacob N, Tanguy M. Nicotine patches in pregnant smokers: randomised, placebo-controlled, multicentre trial of efficacy. BMJ 2014; 348: g1622.
11. Koren G. Nicotine-replacement therapy in pregnancy - the end of the road? Ther Drug Monit 2012; 34: 487-488.
12. Zhu S, Sun J, Bonnevie E et al. Four hundred and sixty brands of e-cigarettes and counting: implications for product regulation. Tob Control 2014; 23: 1113-1119.
13. Bullen C, Howe C, Laugesen M et al. Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet 2013; 382: 1629-1637.
14. Sullivan EA, Laws P, Grayson N. Smoking and pregnancy. Cat. no. PER 33. Canberra: AIHW, 2006.
15. Shipton D, Tappin DM, Vadiveloo T et al. Reliability of selfreported smoking status by pregnant women for estimating smoking prevalence: a retrospective, cross-sectional study. BMJ 2009; 339: b4347.
16. Cook DG, Strachan DP. Health effects of passive smoking 3: parental smoking and prevalence of respiratory symptoms and asthma in school age children. Thorax 1997; 52: 1081-1094.
17. The health consequences of involuntary exposure to tobacco smoke: a report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, Coordinating Center for Health Promotion, National Center for Chronic Disease Prevention and Health Promotion, and Office on Smoking and Health, 2006.
18. Alati R, Mamun AA, O'Callaghan M et al. In utero and postnatal maternal smoking and asthma in adolescence. Epidemiology 2006; 17: 138-144.
19. Peat JK, Toelle BG, Marks GB, Mellis CM. Continuing the debate about measuring asthma in population studies. Thorax 2001; 56: 406-411.
20. Polosa R, Rodu B, Caponnetto P et al. A fresh look at tobacco harm reduction: the case for the electronic cigarette. Harm Reduct J 2013; 10: 19.
21. Phelan S. Smoking cessation in pregnancy. Obstet Gynecol Clin N Amer 2014; 41: 255-266.
22. Chamberlain C, O'Mara-Eves A, Oliver S et al. Psychosocial interventions for supporting women to stop smoking in pregnancy. Cochrane Database Syst Rev 2013; 10. Art. No.: CD001055.
23. Forinash AB, Pitlick JM, Clark K, Alstat V. Nicotine replacement therapy effect on pregnancy outcomes. Ann Pharmacother 2010; 44: 1817-1821.
24. Palazzolo DL. Electronic cigarettes and vaping: a new challenge in clinical medicine and public health. A literature review. Front Public Health 2013; 1: 56.
25. Cobb NK, Abrams DB. E-cigarette or drug-delivery device? Regulating novel nicotine products. N Engl J Med 2011; 365: 193-195.
26. Laugesen M. Safety Report on the Ruyan® e-Cigarette and Inhaled Aerosol. Christchurch: Health New Zealand Ltd, 2008. [Accessed 13 January 2014.] Available from: http://www.healthnz.co.nz/RuyanCartridgeReport30-Oct-08.pdf
27. Westenberger BJ. Evaluation of e-Cigarettes. St. Louis, MO: Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Division of Pharmaceutical Analysis, 2009. [Accessed 13 January 2014.] Available from: http://www.fda.gov/downloads/drugs/Scienceresearch/UCM173250.pdf
28. Cahn Z, Siegel M. Electronic cigarettes as a harm reduction strategy for tobacco control: a step forward or a repeat of past mistakes? J Pub Health Policy 2011; 32: 16-31.
29. Talhout R, Schulz T, Florek E et al. Hazardous compounds in tobacco smoke. Int J Environ Res Public Health 2011; 8: 613-628.
30. Bullen C, McRobbie H, Thornley S et al. Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: randomised cross-over trial. Tob Control 2010; 19: 98-103.
31. Etter JF, Zäther E, Svensson S. Analysis of refill liquids for electronic cigarettes. Addiction 2013; 108: 1671-1679.
32. Vansickel AR, Cobb CO, Weaver MF, Eissenberg TE. A clinical laboratory model for evaluating the acute effects of electronic "cigarettes": nicotine delivery profile and cardiovascular and subjective effects. Cancer Epidemiol Biomarkers Prev 2010; 19: 1945-1953.
33. Trehy M, Ye W, Hadwiger M et al. Analysis of electronic cigarette cartridges, refill solutions and smoke for nicotine and nicotine related impurities. J Liq Chromatogr Relat Technol 2011; 10: 1442-1458.
34. Cahn Z, Siegel M. Electronic cigarettes as a harm reduction strategy for tobacco control: a step forward or a repeat of past mistakes? J Pub Health Policy 2011; 10: 16-31.
35. Coleman T, Chamberlain C, Cooper S et al. Efficacy and safety of nicotine replacement therapy for smoking cessation in pregnancy: systematic review and meta-analysis. Addiction 2011; 106: 52-61.
36. Forinash AB, Pitlick JM, Clark K et al. Nicotine replacement therapy effect on pregnancy outcomes. Ann Pharmacother 2010; 10: 1817-1821.
37. Osadchy A, Kazmin A, Koren G. Nicotine replacement therapy during pregnancy: recommended or not recommended? J Obstet Gynaecol Can 2009; 31: 744-747.
38. Moses A, "Experts wary of e-cigarettes as test run looms", The Sydney Morning Herald, 4 March 2013.
39. Hajek P. Electronic cigarettes for smoking cessation. Lancet 2103; 382: 1614-1616.
40. [Accessed 13th January 2014.] http://www.productsafety. gov.au/content/index.phtml/itemId/974709
41. Brose LS, McEwen A, West R. Association between nicotine replacement therapy and smoking cessation. Drug Alcohol Depend 2013; 132: 660-664.